Concepedia
Statistics
Publications
9
Citations
379
H-Index
Active since
2004
Affiliations
University of Arizona Cancer Center(Current)
Cleveland Clinic
Eon Corporation (United States)
University of Arizona
A. Stopeck is an author at University of Arizona Cancer Center specializing in oncology, medicine, and metastasis.
Publications per year
2004–2011
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases
W. Jeffrey Allard, Jeri Matera, Michael Craig Miller et al. · Journal of Clinical Oncology · 2004 · 164 citations
Medicine, Clinical Sciences, Oncology +15
Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)
Shanu Modi, S. Sugarman, A. Stopeck et al. · Journal of Clinical Oncology · 2008 · 62 citations
Medicine, Oncology, Pharmacology +17
Phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin’s lymphoma (NHL): Southwest Oncology Group Study S0108
A. Stopeck, William Bellamy, Joseph M. Unger et al. · Journal of Clinical Oncology · 2005 · 39 citations
Medicine, Oncology, Pharmacotherapy +16
W. Jeffrey Allard, Jeri Matera, Michael Craig Miller et al. · Journal of Clinical Oncology · 2004 · 38 citations
A phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2+ metastatic breast cancer (MBC)
Hope S. Rugo, Sandra Franco, P.N. Munster et al. · Journal of Clinical Oncology · 2008 · 19 citations
Medicine, Oncology, Pharmacology +16
1–5 of 9